MarketPulse

bempedoic acid

3 articles
BenzingaBenzinga··Vandana Singh

Esperion Therapeutics Surges on $1.1B Archimed Acquisition Deal

Esperion Therapeutics shares surge following $1.1B Archimed acquisition announcement at $3.16 per share plus contingent value rights.
ESPRacquisitioncontingent value rights
BenzingaBenzinga··Na

Athyrium Backs Esperion's $50M Japan Deal to Fund Corstasis Acquisition

Athyrium invests $50M in Esperion via Japan royalty financing to fund Corstasis acquisition, bringing first FDA-approved intranasal loop diuretic to portfolio.
ESPRM&AJapan market
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Esperion Secures Fifth Settlement with Generic Drug Maker Over NEXLETOL, NEXLIZET Patents

Esperion secures fifth settlement with generic drugmaker Alkem, extending market exclusivity for cholesterol drugs NEXLETOL and NEXLIZET through April 2040.
SDZNYESPRpatent settlementgeneric drugs